Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03360890
Brief Title: Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors (iPRIME)

First Submitted : November 20, 2017
First Submitted that Met QC Criteria : December 1, 2017
First Posted : December 4, 2017

Last Update Submitted that Met QC Criteria : September 11, 2020
Last Update Posted : September 16, 2020